VRM
ISEE

Vectors Research Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Vectors Research Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,000
Closed -$29K – 518
2022
Q2 		$29K Buy
+3,000
New +$37.7K 0.01% 264
2022
Q1 		– Sell
-3,000
Closed -$50K – 596
2021
Q4 		$50K Hold
3,000
– – 0.01% 262
2021
Q3 		$49K Hold
3,000
– – 0.01% 241
2021
Q2 		$19K Buy
+3,000
New +$19.4K ﹤0.01% 319

Other funds holding ISEE

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Vectors Research Management's ISEE Position: Q3 2022 in Review

Vectors Research Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022, closing a stake of 3,000 shares — an estimated $29K sold.

Vectors Research Management first reported a position in ISEE in Q2 2021 and held it in 4 quarters. The position peaked at $50K in Q4 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Vectors Research Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Vectors Research Management sold 3,000 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $29K.
  • Vectors Research Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Vectors Research Management's IVERIC bio, Inc. Common Stock position peaked at $50K in Q4 2021.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.